Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

Rod Quilitz, PharmD

ID Clinical Pharmacist
Moffitt Cancer Center

Disclosure(s): No financial relationships to disclose

Poster(s):

483 - Use of Terbinafine in Combination with Other Systemic Anti-fungal Agents As Treatment for Invasive Mold Infections. Experience from A National Cancer Institute Designated Cancer Center.
Thursday, October 20, 2022
12:15 PM – 1:30 PM US ET